R & D and News

PRESS RELEASE: First Review Article on Health Effects of Wax Ester Omega-3s
A recent review article by Schots et al., published in Frontiers in Pharmacology, investigates how the different constituents of Calanus® Oil can contribute to the prevention of obesity-induced low-grade inflammation and the associated metabolic disturbances. Calanus® Oil is a natural oil derived from the 1-year copepod Calanus finmarchicus. In addition to having the unique wax ester form, Calanus® Oil is not refined and therefore contains a broad range of nutrients.

The publication summarizes knowledge of common omega-3 fatty acids like EPA and DHA, and in addtion how stearidonic acid, monounsaturated fatty acids, policosanols and astaxanthin can contribute to the metabolic and inflammatory health in a favorable way.

Head of Science in Calanus AS, Alice Marie Pedersen, PhD, says: “This publication is the first comprehensive review that evaluates the different bioactive constituents of Calanus® Oil. Even if there is still much to discover, there is already exisiting knowledge on for instance policosanols and monounsaturated fatty acids, which are associated with the mediterranean diet“.

The researchers also conclude that the the wax esters likely act as natural delayed release molecules, thereby facilitating transportation of fatty acids to the GPR120 receptors. The fatty acids act as potent stimulators of the GPR120 receptor, which is associated with reduced inflammation, improved insulin sensitivity and enhanced glucose uptake. GPR120 is a target for treatment of obesity and type 2 diabetes.

Dr. Pedersen concludes: „Stearidonic acid is also extremely interesting, and it is likely that this special fatty acid, as a part of the wax ester molecule, could explain many of the benefits we have observed in research and among consumers“.

Calanus® Oil is an omega-3 rich oil, where the fatty acid´s special chemistry gives additional benefits in the metabolic health area. Recent research has shown a favorable impact on body composition, insulin sensitivity and heart pumping efficiency. Calanus® Oil is currently being sold in Europe and North America, with several regualatory approval processes ongoing in other markets.

For further information, please contact Head of Sales and Marketing Jan Erik Olsen on tel. +47 951 45 351 or by e-mail: jan.erik.olsen@calanus.no. Please also refer to the company’s website: www.calanus.no.

More articles about Calanus® Oil

Calanus® Oil prevents negative changes in gut microbiota

Calanus® Oil prevents negative changes in gut microbiota

A new preclinical study conducted by a research team from Uit- The Arctic University of Norway, shows that Calanus® Oil supplementation in obese mice prevents negative changes in microbiota. This has led to new theories about the mechanisms of action of Calanus® Oil.

Clinical trial:  Calanus® Oil improves body composition

Clinical trial: Calanus® Oil improves body composition

A new study conducted by a research team from Leibniz Universität in Hannover, Germany, shows exciting synergistic effects on body composition when combining moderate physical activity with Calanus® Oil supplementation. 134 healthy, untrained participants (96 women...

Calanus® Oil

Calanus® Oil

NorskCalanus® Oil is a new marine oil, which is extracted from the marine crustacean (zooplankton) Calanus finmarchicus.  UNIQUE CHEMISTRY GIVES OTHER BIOMEDICAL EFFECTS The oil is rich in the omega-3 fatty acids EPA, DHA and SDA bound as wax esters (>85%), and has...

PRESS RELEASE: Norway opens for commercial harvesting of zooplankton

PRESS RELEASE: Norway opens for commercial harvesting of zooplankton

NorskTromsø, Norway, April 1st 2019. The Norwegian Government has decided to open for commercial harvesting of Calanus finmarchicus, the small copepod that constitutes the largest renewable and harvestable resource in the Norwegian sea. Based on a precautionary...

DOWNLOAD

To download this document, please fill in your e-mail address first.

DOWNLOAD

To download this document, please fill in your e-mail address first.

DOWNLOAD

To download this document, please fill in your e-mail address first.

DOWNLOAD

To download this document, please fill in your e-mail address first.